• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病与心血管疾病中人类微生物群的比较指纹图谱分析

Comparative Fingerprinting of the Human Microbiota in Diabetes and Cardiovascular Disease.

作者信息

Vamanu Emanuel, Pelinescu Diana, Sarbu Ionela

机构信息

1 Faculty of Biotechnology, University of Agronomic Science and Veterinary Medicine , Bucharest, Romania .

2 Department of Genetics, Faculty of Biology, University of Bucharest , Bucharest, Romania .

出版信息

J Med Food. 2016 Dec;19(12):1188-1195. doi: 10.1089/jmf.2016.0085. Epub 2016 Nov 29.

DOI:10.1089/jmf.2016.0085
PMID:27898282
Abstract

Diabetes and cardiovascular diseases are major causes of morbidity and mortality worldwide, and are associated with changes in the human gut microbiota. To better understand the relationships between diet, disease, and the colonic microbiome, we used the in vitro GIS1 system and repetitive element palindromic polymerase chain reaction (rep-PCR) to determine the microbial fingerprints in individuals with these diseases and compared them with the fingerprints in healthy controls. Clear differences were apparent in the three groups. The diabetes group showed significantly increased aerobic bacteria, increased coliforms, and reduced bifidobacteria; the balance between beneficial and pathogenic bacteria was disturbed; significant numbers of clostridia were present; and the proportions of various major bacterial groups were unstable through the length of the colon. The microbiota of the cardiovascular group had high numbers of beneficial strains and more closely resembled the control microbiota. Different patterns of lactic acid bacteria were observed in the three groups, and there was a direct link between the presence of lactate and the colonic pH. Ammonium, a microbial metabolite associated with colonic cancer, was associated with consistently high levels of Gram-positive bacteria in the diabetic patients. In the cardiovascular patients and controls, each colonic segment showed a distinct microbial fingerprint, whereas in the diabetics, the same rep-PCR profile occurred in all three segments. The diversity of beneficial bacteria was reduced in patients with a nutritional or cardiovascular disease. Both diabetes and cardiovascular disease are associated with changes in the colonic microbial fingerprint. This study of microbial microbiota fingerprint modification has direct applicability in medical practice.

摘要

糖尿病和心血管疾病是全球发病和死亡的主要原因,且与人类肠道微生物群的变化有关。为了更好地理解饮食、疾病和结肠微生物组之间的关系,我们使用体外GIS1系统和重复元件回文聚合酶链反应(rep-PCR)来确定患有这些疾病的个体的微生物指纹图谱,并将其与健康对照的指纹图谱进行比较。三组之间存在明显差异。糖尿病组需氧菌显著增加、大肠菌增加、双歧杆菌减少;有益菌和致病菌之间的平衡受到干扰;存在大量梭菌;并且在整个结肠长度上各种主要细菌群的比例不稳定。心血管疾病组的微生物群中有大量有益菌株,与对照微生物群更为相似。在三组中观察到不同模式的乳酸菌,并且乳酸的存在与结肠pH值之间存在直接联系。铵是一种与结肠癌相关的微生物代谢产物,与糖尿病患者中革兰氏阳性菌的持续高水平有关。在心血管疾病患者和对照组中,每个结肠段都显示出独特的微生物指纹图谱,而在糖尿病患者中,所有三个段都出现相同的rep-PCR图谱。患有营养性疾病或心血管疾病的患者中有益菌的多样性降低。糖尿病和心血管疾病都与结肠微生物指纹的变化有关。这项关于微生物群指纹图谱改变的研究在医学实践中有直接的应用价值。

相似文献

1
Comparative Fingerprinting of the Human Microbiota in Diabetes and Cardiovascular Disease.糖尿病与心血管疾病中人类微生物群的比较指纹图谱分析
J Med Food. 2016 Dec;19(12):1188-1195. doi: 10.1089/jmf.2016.0085. Epub 2016 Nov 29.
2
Listening to Our Gut: Contribution of Gut Microbiota and Cardiovascular Risk in Diabetes Pathogenesis.倾听我们的肠道:肠道微生物群在糖尿病发病机制中的作用及心血管风险
Curr Diab Rep. 2015 Sep;15(9):63. doi: 10.1007/s11892-015-0634-1.
3
Blood Microbiota and Circulating Microbial Metabolites in Diabetes and Cardiovascular Disease.血液微生物组和糖尿病及心血管疾病中的循环微生物代谢产物。
Trends Endocrinol Metab. 2020 Nov;31(11):835-847. doi: 10.1016/j.tem.2020.01.013. Epub 2020 Feb 11.
4
Effect of inulin on the human gut microbiota: stimulation of Bifidobacterium adolescentis and Faecalibacterium prausnitzii.菊粉对人体肠道微生物群的影响:刺激青春双歧杆菌和普拉梭菌。
Br J Nutr. 2009 Feb;101(4):541-50. doi: 10.1017/S0007114508019880. Epub 2008 Jul 1.
5
Use of repetitive element palindromic PCR (rep-PCR) for the epidemiologic discrimination of foodborne pathogens.利用重复元件回文PCR(rep-PCR)对食源性病原体进行流行病学鉴别。
Methods Mol Biol. 2009;551:49-58. doi: 10.1007/978-1-60327-999-4_5.
6
[Species Diversity of Bifidobacteria in the Intestinal Microbiota Studied Using MALDI-TOF Mass-Spectrometry].[使用基质辅助激光解吸电离飞行时间质谱法研究肠道微生物群中双歧杆菌的物种多样性]
Vestn Ross Akad Med Nauk. 2015(4):435-40.
7
Characterization of bacteria, clostridia and Bacteroides in faeces of vegetarians using qPCR and PCR-DGGE fingerprinting.使用 qPCR 和 PCR-DGGE 指纹图谱分析素食者粪便中的细菌、梭菌和拟杆菌。
Ann Nutr Metab. 2009;54(4):253-7. doi: 10.1159/000229505. Epub 2009 Jul 27.
8
Transit time affects the community stability of Lactobacillus and Bifidobacterium species in an in vitro model of human colonic microbiotia.在人类结肠微生物群的体外模型中,转运时间会影响乳酸杆菌属和双歧杆菌属的群落稳定性。
Artif Cells Blood Substit Immobil Biotechnol. 2011 Dec;39(6):351-6. doi: 10.3109/10731199.2011.622280.
9
Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2 Ingestion Induces a Less Inflammatory Cytokine Profile and a Potentially Beneficial Shift in Gut Microbiota in Older Adults: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study.摄入加氏乳杆菌KS-13、两歧双歧杆菌G9-1和长双歧杆菌MM-2可诱导老年人产生炎症细胞因子水平降低,并使肠道微生物群发生潜在有益转变:一项随机、双盲、安慰剂对照、交叉研究。
J Am Coll Nutr. 2015;34(6):459-69. doi: 10.1080/07315724.2014.983249. Epub 2015 Apr 24.
10
Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.克罗恩病患者粪便微生物群落中产生丁酸盐的细菌种类丰度降低
Digestion. 2016;93(1):59-65. doi: 10.1159/000441768. Epub 2016 Jan 14.

引用本文的文献

1
Gut Microbiota Modulation by Selenium and Zinc Enrichment Postbiotic on Dysbiosis Associated with Hypertension.富硒锌后生元对与高血压相关的肠道菌群失调的调节作用
Curr Vasc Pharmacol. 2024;22(5):365-374. doi: 10.2174/0115701611290537240509061549.
2
In Vitro and In Vivo Antihyperglycemic Effects of New Metabiotics from .来自……的新型代谢物的体外和体内降血糖作用
Life (Basel). 2023 Dec 30;14(1):68. doi: 10.3390/life14010068.
3
The Modulation Effect of a Fermented Bee Pollen Postbiotic on Cardiovascular Microbiota and Therapeutic Perspectives.
发酵蜂花粉后生元对心血管微生物群的调节作用及治疗前景
Biomedicines. 2023 Oct 5;11(10):2712. doi: 10.3390/biomedicines11102712.
4
Extract-A New Modulator of Dysbiotic Microbiota.提取物——一种失调微生物群的新型调节剂。
Life (Basel). 2023 Jun 30;13(7):1481. doi: 10.3390/life13071481.
5
Pharmacomicrobiomics and type 2 diabetes mellitus: A novel perspective towards possible treatment.药物微生物组学与 2 型糖尿病:一种新的治疗视角。
Front Endocrinol (Lausanne). 2023 Mar 23;14:1149256. doi: 10.3389/fendo.2023.1149256. eCollection 2023.
6
Pharmacomicrobiomics in Western Medicine and Traditional Chinese Medicine in Type 2 Diabetes.西药的药物微生物组学与 2 型糖尿病的中医药
Front Endocrinol (Lausanne). 2022 May 4;13:857090. doi: 10.3389/fendo.2022.857090. eCollection 2022.
7
From Tumor Cells to Endothelium and Gut Microbiome: A Complex Interaction Favoring the Metastasis Cascade.从肿瘤细胞到内皮细胞和肠道微生物群:促进转移级联反应的复杂相互作用。
Front Oncol. 2022 May 5;12:804983. doi: 10.3389/fonc.2022.804983. eCollection 2022.
8
The Link between Obesity, Microbiota Dysbiosis, and Neurodegenerative Pathogenesis.肥胖、微生物群失调与神经退行性病变发病机制之间的联系
Diseases. 2021 Jun 23;9(3):45. doi: 10.3390/diseases9030045.
9
In Vitro Modulatory Effect of Stevioside, as a Partial Sugar Replacer in Sweeteners, on Human Child Microbiota.甜菊糖苷作为甜味剂中部分糖替代品对儿童人体微生物群的体外调节作用
Microorganisms. 2021 Mar 13;9(3):590. doi: 10.3390/microorganisms9030590.
10
Assessing the efficacy and impact of a personalised smoking cessation intervention among type 2 diabetic smokers: study protocol for an open-label randomised controlled trial (DISCGO-RCT).评估个性化戒烟干预措施在 2 型糖尿病吸烟者中的疗效和影响:一项开放标签随机对照试验(DISCGO-RCT)的研究方案。
BMJ Open. 2020 Nov 19;10(11):e040117. doi: 10.1136/bmjopen-2020-040117.